KYTX
Kyverna Therapeutics Inc.

965
Mkt Cap
$414.76M
Volume
583,825.00
52W High
$13.67
52W Low
$1.78
PE Ratio
-1.95
KYTX Fundamentals
Price
$7.26
Prev Close
$7.36
Open
$7.40
50D MA
$8.45
Beta
1.92
Avg. Volume
990,220.05
EPS (Annual)
-$3.33
P/B
2.09
Rev/Employee
$0.00
$134.37
Loading...
Loading...
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
112

Frequently Asked Questions

What is Market Cap of Kyverna Therapeutics Inc.?
What is the 52-week high for Kyverna Therapeutics Inc.?
What is the 52-week low for Kyverna Therapeutics Inc.?
What is Kyverna Therapeutics Inc. stock price today?
What was Kyverna Therapeutics Inc. stock price yesterday?
What is the PE ratio of Kyverna Therapeutics Inc.?
What is the Price-to-Book ratio of Kyverna Therapeutics Inc.?
What is the 50-day moving average of Kyverna Therapeutics Inc.?
How many employees does Kyverna Therapeutics Inc. have?

Latest KYTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.